Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (151-160 of 560) with videos related to

Pageof 56
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 22, 2020
Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single centerArjun Sivaraman, Giancarlo Marra, Armando Stabile, et al.
European Urology|August 13, 2015
Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical ProstatectomyMarco Moschini, Alberto Briganti, Christopher R Murphy, et al.
Minerva Urology and Nephrology|March 11, 2022
Comment on: Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposalFrancesco Del Giudice, Benjamin I Chung, Marco Moschini, et al.
European Urology|July 2, 2020
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled TrialsMohammad Abufaraj, Takehiro Iwata, Shoji Kimura, et al.
Clinical Genitourinary Cancer|March 3, 2026
Efficacy and Safety of Intravesical Gemcitabine and Docetaxel Combination Therapy in Patients With Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisPiotr Domański, Karolina Hanusz, Łukasz Zapała, et al.
Minerva Urology and Nephrology|May 24, 2022
A gender-related dichotomy in bladder cancerAlessia Cimadamore, Jeremy Y Teoh, Ettore DI Trapani, et al.
European Urology Oncology|November 4, 2022
Epidemiology, Screening, and Prevention of Bladder CancerNiyati Lobo, Luca Afferi, Marco Moschini, et al.
BJU International|March 14, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomyDavid D'Andrea, Francesco Soria, Marco Moschini, et al.
Urologic Oncology|April 1, 2017
Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade groupingGiorgio Gandaglia, R Jeffrey Karnes, Arjun Sivaraman, et al.
Urologic Oncology|February 19, 2017
Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancerMohammad Abufaraj, Shahrokh F Shariat, Andrea Haitel, et al.
Pageof 56

Showing results (151-160 of 560) with videos related to

Sort By:
Pageof 56
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 22, 2020
Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single centerArjun Sivaraman, Giancarlo Marra, Armando Stabile, et al.
European Urology|August 13, 2015
Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical ProstatectomyMarco Moschini, Alberto Briganti, Christopher R Murphy, et al.
Minerva Urology and Nephrology|March 11, 2022
Comment on: Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposalFrancesco Del Giudice, Benjamin I Chung, Marco Moschini, et al.
European Urology|July 2, 2020
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled TrialsMohammad Abufaraj, Takehiro Iwata, Shoji Kimura, et al.
Clinical Genitourinary Cancer|March 3, 2026
Efficacy and Safety of Intravesical Gemcitabine and Docetaxel Combination Therapy in Patients With Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisPiotr Domański, Karolina Hanusz, Łukasz Zapała, et al.
Minerva Urology and Nephrology|May 24, 2022
A gender-related dichotomy in bladder cancerAlessia Cimadamore, Jeremy Y Teoh, Ettore DI Trapani, et al.
European Urology Oncology|November 4, 2022
Epidemiology, Screening, and Prevention of Bladder CancerNiyati Lobo, Luca Afferi, Marco Moschini, et al.
BJU International|March 14, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomyDavid D'Andrea, Francesco Soria, Marco Moschini, et al.
Urologic Oncology|April 1, 2017
Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade groupingGiorgio Gandaglia, R Jeffrey Karnes, Arjun Sivaraman, et al.
Urologic Oncology|February 19, 2017
Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancerMohammad Abufaraj, Shahrokh F Shariat, Andrea Haitel, et al.
Pageof 56